Atea Pharmaceuticals, Inc. Common Stock

AVIRNASDAQ • USD
ThemeBiotech - Drug Development›Infectious Disease & Vaccines
4.25 USD
↘ 0.17 (3.85%)AT CLOSE (11:59 AM EDT)
4.25
↘ 0.01 (0.12%)
POST MARKET (AS OF 04:31 PM EDT)
Post Market
AS OF 04:31 PM EDT
4.25
↘ 0.01 (0.12%)
🔴Market: CLOSED
Open?$4.42
High?$4.43
Low?$4.24
Prev. Close?$4.42
Volume?217.6K
Avg. Volume?328.7K
VWAP?$4.32
Rel. Volume?0.66x
Bid / Ask
Bid?$4.23 × 100
Ask?$4.89 × 100
Spread?$0.66
Midpoint?$4.56
Valuation & Ratios
Market Cap?340.1M
Shares Out?80.0M
Float?54.5M
Float %?69.8%
P/E Ratio?N/A
P/B Ratio?1.46
EPS?-$2.12
Dividend?0.00%
Ex-Dividend?N/A

Atea Pharmaceuticals, Inc. Common Stock (AVIR) trades at $4.25 per share. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, AVIR appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
Themes
Biotech - Drug Development›Infectious Disease & Vaccines
Employees
55
Market Cap
340.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.ateapharma.com
Listed
2020-10-30
Address
225 FRANKLIN STREET
BOSTON, MA 02110
Phone: (857) 284-8891
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
30
Momentum?
23
Short Sent.?
28
Piotroski F-Score?0/9Weak
Altman Z-Score?1.83Grey
Confidence?65%Moderate
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?13.93%High
Short Interest?7.6M
Days to Cover?19.7
Free Float54.5M
Avg Daily Volume384.8K
Settlement Date2026-05-15
Financial Health
Current Ratio?7.89Strong
Quick Ratio?7.89Strong
Cash Ratio?2.38Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
88
1.46CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.4CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-72.5%WEAK▾
ROA?
S&P
3
-63.5%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$260.8M
Fundamentals ratios updated end of day
MarketsMoversWatchlist